Skip to content

The effect of Satureja hortensis L. cream in treatment vulvovaginal candidiasis

Comparing the effect of Satureja hortensis L. and clotrimazole vaginal cream in treatment of Candida vulvovaginitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180202038591N1
Enrollment
84
Registered
2018-02-15
Start date
2018-03-05
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Candidal vulvovaginitis. Candidiasis of vulva and vagina

Interventions

Intervention 1: Intervention group: Satureja hortensis L vaginal cream 1%, one applicator per day for 1 week. Intervention 2: Control group: Clotrimazole vaginal cream1%, one applicator per day for 1

Sponsors

Ahvaz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Signs and symptoms of vulvovaginal candidiasis Positive Gram staining smear Culture from vaginal discharge

Exclusion criteria

Exclusion criteria: Age between 18 -45 Being married Only sexual partner Signs and symptoms of vulvovaginal candidiasis Positive Gram staining smear Culture from vaginal discharge The absence of any known medical condition Lack of any allergy to coltriamzol cream and Satureja hortensis L Completion of written consent form for examination and sampling

Design outcomes

Primary

MeasureTime frame
Vaginal Discharge. Timepoint: Before intervention, 7 days after treatment. Method of measurement: Clinical Examination, Observation and Medical history.;Itching. Timepoint: Before intervention, 7 days after treatment. Method of measurement: History.;Vulva and Vaginal Burning. Timepoint: Before intervention, 7 days after treatment. Method of measurement: History.;Vaginal discharge culture results. Timepoint: Before intervention, 7 days after treatment. Method of measurement: Vaginal discharge culture.;Compelet remission. Timepoint: Before intervention, 7 days after treatment. Method of measurement: Evauation of clinical symptom's remission and negetive result of vaginal discharge culture.

Secondary

MeasureTime frame
Dyspareunia. Timepoint: Before intervention, 7 days after treatment. Method of measurement: History.;Side Effects. Timepoint: Before intervention, 7 days after treatment. Method of measurement: Question of patient.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShirin Jaldani

Ahvaz University of Medical Sciences

Shirin.jaldani@gmail.com+98 61 3336 1984

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026